Table 2 Population Proportion of new Long COVID symptoms

Prolonged Generalized Weakness

0

788; 31.4%

533

0.21 [0.19-0.22]

Fatigue

132; 5.3%

765; 30.5%

475

0.18 [0.17-0.20]

Sleep problems or disturbance

0

407; 16.2%

407

0.16 [0.14-0.17]

Cough

24; 1%

398; 15.9%

374

0.14 [0.13-0.16]

Muscle pain

47; 1.9%

419; 16.7%

372

0.14 [0.13-0.16]

General Arthralgia

44; 1.8%

359; 14.3%

315

0.12 [0.11-0.13]

Anxiety based on the YRS scale

68; 2.7%

375; 15%

307

0.12 [0.10-0.13]

Depression based on the YRS scale

67; 2.7%

373; 14.9%

306

0.12 [0.10-0.13]

The problem with playing a social role

61; 2.4%

364; 14.5%

303

0.12 [0.10-0.13]

Headache

19; 0.8%

308; 12.3%

289

0.11 [0.10-0.12]

The problem in Activities of Daily Living

48; 1.9%

301; 12%

253

0.10 [0.08-0.11]

Dizziness

0

272; 10.8%

272

0.10 [0.09-0.12]

Prolonged Fever

0

246; 9.8%

246

0.09 [0.08-0.11]

Memory problem

28; 1.1%

257; 10.3%

229

0.09 [0.08-0.10]

Problem with personal care

38; 1.5%

265; 10.6%

227

0.09 [0.07-0.10]

Problem in Concentration

34; 1.4%

250; 10%

216

0.08 [0.07-0.09]

Breathlessness or Dyspnea

116; 4.6%

321; 12.8%

205

0.08 [0.07-0.09]

Mobility problem

41; 1.6%

238; 9.5%

197

0.07 [0.06-0.08]

Palpitation

0

150; 6%

150

0.05 [0.05-0.06]

Chest pain

11; 0.4%

104; 4.1%

93

0.03 [0.03-0.04]

Skin Rash

0

66; 2.6%

66

0.02 [0.02-0.03]

Swallowing and feeding problem

0

30; 1.2%

30

0.01 [0.008-0.01]

Communication problem

14; 0.6%

42; 1.7%

28

0.01 [0.007-0.01]

Voice change

6; 0.2%

21; 0.8%

15

0.006 [0.003-0.009]

Problem with executing a plan

6; 0.2%

22; 0.9%

16

0.006 [0.003-0.01]

PTSD based on the YRS scale

4; 0.2%

20; 0.8%

16

0.006 [0.003-0.01]

Abdominal Pain

6; 0.2%

20; 0.8%

14

0.005 [0.003-0.009]

Noisy breathing

6; 0.2%

14; 0.6%

8

0.003 [0.001-0.006]

Bladder control problem

5; 0.2%

7; 0.3%

2

0.001 [0.0001-0.002]

Bowel control problem

4; 0.2%

5; 0.2%

1

0.001 [0.00001-0.002]